What are healthy cholesterol levels. How does diet impact cholesterol. What lifestyle changes can lower cholesterol. When should medication be considered for high cholesterol. How is cholesterol tested and monitored. What are the risks of high cholesterol. How is cholesterol linked to heart disease.

What is Cholesterol and Why Does it Matter?

Cholesterol is a waxy, fat-like substance found in all cells of the body. While often vilified, cholesterol actually plays several important roles:

• It helps produce hormones like testosterone and estrogen
• It aids in vitamin D production
• It’s used to make bile acids that help digest food
• It’s a key component of cell membranes

However, having too much cholesterol in the bloodstream can lead to serious health issues. High cholesterol levels can contribute to the formation of plaque in arteries, increasing the risk of heart disease and stroke.

Types of Cholesterol

There are two main types of cholesterol:

1. LDL (Low-Density Lipoprotein) – Often called “bad” cholesterol, as it can contribute to plaque buildup in arteries
2. HDL (High-Density Lipoprotein) – Known as “good” cholesterol, as it helps remove other forms of cholesterol from the bloodstream

Understanding the balance between these types is crucial for assessing cardiovascular health.

Interpreting Cholesterol Numbers: What Do They Mean?

Cholesterol levels are measured in milligrams per deciliter (mg/dL) of blood. For adults, the following guidelines are generally used:

• Total Cholesterol: Less than 200 mg/dL is considered desirable
• LDL Cholesterol: Less than 100 mg/dL is optimal
• HDL Cholesterol: 60 mg/dL or higher is considered protective against heart disease

In the case presented, a total cholesterol level of 210 mg/dL is slightly above the desirable range. However, it’s important to note that a single number doesn’t tell the whole story. The balance between LDL and HDL, as well as other risk factors, must be considered.

Risk Factors and Individual Assessment

Several factors can influence how cholesterol levels impact overall health:

• Age and gender
• Family history of heart disease
• Smoking status
• Blood pressure
• Diabetes
• Weight and physical activity level

In the case of the 26-year-old individual with a family history of heart disease, this background information becomes particularly relevant in assessing their overall cardiovascular risk.

The Impact of Diet on Cholesterol Levels

Diet plays a crucial role in managing cholesterol levels. Certain foods can help lower cholesterol, while others can raise it. Here are some dietary guidelines for managing cholesterol:

Foods to Limit or Avoid

• Saturated fats (found in red meat, full-fat dairy products, and some tropical oils)
• Trans fats (often found in processed and fried foods)
• Excessive dietary cholesterol (found in egg yolks, organ meats, and shellfish)

Foods to Increase

• Soluble fiber (found in oats, beans, lentils, and some fruits)
• Omega-3 fatty acids (found in fatty fish like salmon, mackerel, and sardines)
• Plant sterols and stanols (naturally occurring in small amounts in many plants and grains)

Can changing your diet really make a difference in cholesterol levels? Research suggests that adopting a heart-healthy diet can lower LDL cholesterol by 10% to 30%, which is significant in terms of reducing cardiovascular risk.

Lifestyle Changes for Managing Cholesterol

While diet is crucial, other lifestyle factors also play a significant role in managing cholesterol levels:

Exercise and Physical Activity

Regular physical activity can help increase HDL cholesterol while lowering LDL cholesterol and triglycerides. Aim for at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity aerobic activity per week.

Weight Management

Maintaining a healthy weight can help improve cholesterol levels. Even a small weight loss (5-10% of body weight) can significantly impact cholesterol and other heart disease risk factors.

Smoking Cessation

Quitting smoking can improve HDL cholesterol levels and overall cardiovascular health. Within just one year of quitting, your risk of heart disease drops dramatically.

Stress Management

Chronic stress can negatively impact cholesterol levels and overall heart health. Incorporating stress-reduction techniques like meditation, yoga, or deep breathing exercises can be beneficial.

When to Consider Medication for High Cholesterol

While lifestyle changes are the first line of defense against high cholesterol, sometimes medication may be necessary. Statins are the most commonly prescribed cholesterol-lowering drugs, but other options exist as well.

When is medication typically recommended? Factors that may influence this decision include:

• Very high LDL cholesterol levels (190 mg/dL or higher)
• Presence of cardiovascular disease
• Diabetes
• High risk of developing heart disease based on other risk factors

It’s important to note that medication should always be used in conjunction with lifestyle changes, not as a replacement for them.

The Link Between Cholesterol and Heart Disease

Understanding the connection between cholesterol and heart disease is crucial for appreciating the importance of cholesterol management. High levels of LDL cholesterol can lead to the formation of plaque in the arteries, a condition known as atherosclerosis.

How does this process occur? LDL cholesterol can build up in the walls of arteries, causing them to narrow and harden. This makes it harder for blood to flow through, increasing the risk of heart attack and stroke.

On the other hand, HDL cholesterol helps remove excess cholesterol from the bloodstream, transporting it back to the liver for disposal. This is why having higher levels of HDL cholesterol is considered protective against heart disease.

The Role of Inflammation

Recent research has highlighted the role of inflammation in the development of heart disease. Chronic inflammation can damage the inner lining of arteries, making it easier for cholesterol to accumulate. This underscores the importance of an overall healthy lifestyle in preventing heart disease, beyond just managing cholesterol levels.

Monitoring and Testing Cholesterol Levels

Regular cholesterol testing is an important part of maintaining cardiovascular health. But how often should cholesterol levels be checked?

• For adults with no risk factors: Every 4-6 years
• For adults with cardiovascular risk factors: More frequently, as recommended by a healthcare provider
• For children and adolescents: Once between ages 9-11, and again between ages 17-21

The standard test for checking cholesterol levels is called a lipid panel or lipid profile. This blood test measures:

• Total cholesterol
• LDL cholesterol
• HDL cholesterol
• Triglycerides (another type of fat in the blood)

In some cases, additional tests may be recommended to get a more detailed picture of cardiovascular risk. These might include:

• Apolipoprotein B (ApoB) test
• Lipoprotein(a) test
• High-sensitivity C-reactive protein (hs-CRP) test to measure inflammation

Fasting vs. Non-Fasting Tests

Traditionally, lipid panels were done after a 9-12 hour fast. However, recent research suggests that non-fasting tests can be just as accurate for most people. This can make testing more convenient and accessible.

Cholesterol Management Across Different Life Stages

Cholesterol management needs can change throughout life. Let’s explore some considerations for different age groups:

Children and Adolescents

While cholesterol issues are often associated with adults, they can affect children too. Risk factors for high cholesterol in children include:

• Obesity
• Family history of high cholesterol or early heart disease
• Certain medical conditions (like diabetes or kidney disease)

For children, the focus is primarily on maintaining a healthy lifestyle through proper diet and regular physical activity.

Young Adults

Young adults, like the 26-year-old in our example, may not always prioritize cholesterol management. However, this is an excellent time to establish heart-healthy habits that can pay dividends later in life. Regular check-ups and awareness of family history are important.

Middle-Aged Adults

As people enter middle age, the risk of high cholesterol increases. This is a crucial time for regular screening and proactive management. Lifestyle factors become even more important, and medication may be considered if lifestyle changes alone aren’t sufficient.

Older Adults

For older adults, cholesterol management can be more complex. While high cholesterol remains a risk factor for heart disease, very low cholesterol levels may also be concerning in some cases. Individualized care becomes especially important in this age group.

Natural Remedies and Supplements for Cholesterol Management

While diet, exercise, and sometimes medication are the mainstays of cholesterol management, some natural remedies and supplements have shown promise in supporting healthy cholesterol levels. However, it’s crucial to remember that these should be used under medical supervision and not as a replacement for prescribed treatments.

Promising Natural Remedies

• Garlic: Some studies suggest garlic may help lower total and LDL cholesterol
• Green tea: Rich in antioxidants, green tea may help lower LDL cholesterol and raise HDL cholesterol
• Niacin: A B vitamin that can boost HDL cholesterol (high doses should only be taken under medical supervision)
• Psyllium: A type of soluble fiber that can help lower LDL cholesterol

Supplements to Consider

• Fish oil: Rich in omega-3 fatty acids, which can help lower triglycerides
• Plant sterols and stanols: These can help block cholesterol absorption in the intestines
• Red yeast rice: Contains compounds similar to statins, but should be used with caution and medical supervision

Remember, while these natural remedies and supplements can be beneficial, they can also interact with medications or have side effects. Always consult with a healthcare provider before starting any new supplement regimen.

The Future of Cholesterol Management

As our understanding of cholesterol and cardiovascular health continues to evolve, new approaches to management are emerging. Here are some exciting developments in the field:

Personalized Medicine

Advances in genetic testing are allowing for more personalized approaches to cholesterol management. By identifying specific genetic markers, healthcare providers can tailor treatments more effectively to individual patients.

New Medications

While statins remain the primary medication for managing high cholesterol, new drugs are being developed and tested. For example, PCSK9 inhibitors represent a new class of cholesterol-lowering drugs that have shown promise for patients who don’t respond well to statins.

Advanced Imaging Techniques

New imaging technologies are allowing for earlier and more precise detection of atherosclerosis. This can help in identifying high-risk individuals before they develop symptoms of heart disease.

Lifestyle Interventions

There’s increasing focus on comprehensive lifestyle interventions that go beyond just diet and exercise. These programs may incorporate stress management, sleep optimization, and even mindfulness practices to support overall cardiovascular health.

As research continues, our strategies for managing cholesterol and preventing heart disease will undoubtedly become more sophisticated and effective. However, the foundational principles of maintaining a healthy lifestyle remain crucial in the fight against high cholesterol and heart disease.

Cholesterol Level 210 – My Cholesterol Level Is 210. My Age Is

1. Home
2. Consult with a doctor
3. Diet Advice and Tips

CHOLESTEROL LEVEL 210

Asked for Male, 25 Years

My cholesterol level is 210. My age is 26. I have been a lot of junk food and family has a heart disease.

882 Views

v

Understanding Cholesterol, Triglycerides, Hdl Cholesterol and Ldl Cholesterol

Ms. Pallavi Jassal

It is important to have an understanding of different types of Lipids circulating in the blood in the form of Cholestero

…

Read more

6

Cholesterol Is Healthy & Wealthy for the Heart

Dr.Neelam Nath Bhatia

Can we run our vehicle without good oil? Why do we get our vehicles serviced, get filter & oil changed after driving

…

Read more

2

How to Interpret Your Cholesterol/ Lipid Profile Report

Dr. Himanshu Yadav

We often see when we get our lipid profile report, there are many variables in it like Total cholesterol, LDL, HDL, Trig

…

Read more

8

Reduce Your Cholesterol

Dr.Geeta Pawar

HIGH BLOOD CHOLESTEROL & HOMEOPATHY. Keeping your Cardio vascular system healthy is a significant p

…

Read more

6

Lowering Your Cholesterol, It’s in Your Hand

Dr. Shelja

Cholesterol is an essential lipid that helps your body function properly. It has many functions including helping your g

…

Read more

6

Does Fiber Helps in Controlling Cholesterol Levels?

Ms.Ashu Gupta

Dietary fiber or roughage is the portion of plant-derived food that cannot be completely broken down by digestive enzyme

…

Read more

1

Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Diet Advice and Tips

Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population

1. Aekplakorn W, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Putwatana P, Sritara P, Sangwatanaroj S, Chariyalertsak S. Prevalence of dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009. J Lipids. 2014;2014:249584. doi: 10.1155/2014/249584. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

2. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al. Heart disease and stroke Statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. doi: 10.1161/CIR.0000000000000558. [PubMed] [CrossRef] [Google Scholar]

3. Gowshall M, Taylor-Robinson SD. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi. Int J Gen Med. 2018;11:255–264. doi: 10.2147/IJGM.S157987. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Bilen O, Kamal A, Virani SS. Lipoprotein abnormalities in south Asians and its association with cardiovascular disease: current state and future directions. World J Cardiol. 2016;8(3):247–257. doi: 10.4330/wjc.v8.i3.247. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

5. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328(5):313–318. doi: 10.1056/NEJM199302043280504. [PubMed] [CrossRef] [Google Scholar]

6. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257(16):2176–2180. doi: 10.1001/jama.1987.03390160062027. [PubMed] [CrossRef] [Google Scholar]

7. Pletcher MJ, Bibbins-Domingo K, Liu K, Sidney S, Lin F, Vittinghoff E, Hulley SB. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (coronary artery risk development in young adults) study. Ann Intern Med. 2010;153(3):137–146. doi: 10.7326/0003-4819-153-3-201008030-00004. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

8. Corvilain B, Matte J, Litvine C. Serum cholesterol in young men and cardiovascular disease. N Engl J Med. 1993;329(2):138. [PubMed] [Google Scholar]

9. Clark CJAA, Spencer RA, Pencina M, Williams K, Everson-Rose SA. Predicted long-term cardiovascular risk among young adults in the national longitudinal study of adolescent health. Am J Public Health. 2014;104(12):e108–e115. doi: 10.2105/AJPH.2014.302148. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

10. Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Sr., Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2935–2959. [PMC free article] [PubMed]

11. Chou R, Dana T, Blazina I, Daeges M, Bougatsos C, Jeanne TL. Screening for dyslipidemia in younger adults: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2016;165(8):560–564. doi: 10.7326/M16-0946. [PubMed] [CrossRef] [Google Scholar]

12. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, et al. American Association of Clinical Endocrinologists and American College of endocrinology guidelines for Management of Dyslipidemia and Prevention of cardiovascular disease. Endocr Pract. 2017;23(Suppl 2):1–87. doi: 10.4158/EP171764.APPGL. [PubMed] [CrossRef] [Google Scholar]

13. The Royal College of Physician of Thailand: RCPT Clinical Practice Guideline on Pharmacologic Therapy of Dyslipemia for Arherosclerotic Cardiovascular Disease Prevention. In.; 2016.

14. A systematic Review to Update the 2008 U.S. Preventive services task force recommendation [https://www.ncbi.nlm.nih.gov/books/NBK396239/].

15. Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J, Jongudomsuk P, Sirilak S. Achieving universal health coverage goals in Thailand: the vital role of strategic purchasing. Health Policy Plan. 2015;30(9):1152–1161. doi: 10.1093/heapol/czu120. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

16. Teerawattananon Y, Kingkaew P, Koopitakkajorn T, Youngkong S, Tritasavit N, Srisuwan P, Tantivess S. Development of a health screening package under the universal health coverage: the role of health technology assessment. Health Econ. 2016;25(Suppl Suppl 1):162–178. doi: 10.1002/hec.3301. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

17. Chen Q-J, Lai H-M, Chen B-D, Li X-M, Zhai H, He C-H, Pan S, Luo J-Y, Gao J, Liu F, et al. Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factors among Uygur adults in Xinjiang, China. Int J Environ Res Public Health. 2016;13(2):235. doi: 10.3390/ijerph23020235. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. World Health Organization: Noncommunicable diseases global monitoring framework: indicator definitions and specifications. 2014.

19. Zhang GM, Bai SM, Zhang GM, Ma XB, Goyal H. A novel method for estimating low-density lipoprotein (LDL) levels: Total cholesterol and non-high-density lipoprotein (HDL) can be used to predict abnormal LDL level in an apparently healthy population. Med Sci Monit. 2018;24:1688–1692. doi: 10.12659/MSM.909226. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, Nakatani T, Miki T, Inaba M. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl. 2003;84:S117–S120. doi: 10.1046/j.1523-1755.63.s84.30.x. [PubMed] [CrossRef] [Google Scholar]

21. Carbayo Herencia JA, Simarro Rueda M, Palazon Bru A, Molina Escribano F, Ponce Garcia I, Artigao Rodenas LM, Caldevilla Bernardo D, Divison Garrote JA, Gil Guillen VF, Todos en nombre del Grupo de Enfermedades Vasculares de a: Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort. Clin Investig Arterioscler 2018, 30(2):64–71. [PubMed]

22. Angkurawaranon C, Wisetborisut A, Jiraporncharoen W, Likhitsathian S, Uaphanthasath R, Gomutbutra P, Jiraniramai S, Lerssrimonkol C, Aramrattanna A, Doyle P, et al. Chiang Mai University health worker study aiming toward a better understanding of noncommunicable disease development in Thailand: methods and description of study population. Clinical Epidemiology. 2014;6:277–286. doi: 10.2147/CLEP.S65338. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

23. World Health Organization . WHO STEPS surveillance manual. 2017. The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS) [Google Scholar]

24. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Jama. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486. [PubMed] [CrossRef] [Google Scholar]

25. Veghari G, Sedaghat M, Joshghani H, Niknezad F, Angizeh A, Tazik E, Moharloei P, Banihashem S. Plasma total cholesterol level and some related factors in northern Iranian people. J Nat Sci Biol Med. 2013;4(2):359–363. doi: 10.4103/0976-9668.117008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

26. Costa J, Borges M, Oliveira E, Gouveia M, Carneiro AV. Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review Part III. Rev Port Cardiol. 2003;22(6):829–836. [PubMed] [Google Scholar]

27. Jeong SM, Choi S, Kim K, Kim SM, Lee G, Park SY, Kim YY, Son JS, Yun JM, Park SM. Effect of change in Total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 2018;7(12):1–17. doi: 10.1161/JAHA.118.008819. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

28. Nagasawa S-y, Okamura T, Iso H, Tamakoshi A, Yamada M, Watanabe M, Murakami Y, Miura K, Ueshima H, for the Evidence for cardiovascular prevention from observational cohorts in Japan research G: Relation between serum Total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan. J Am Heart Assoc 2012, 1(5):e001974. [PMC free article] [PubMed]

29. Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32. doi: 10.1016/j.jff.2013.12.006. [CrossRef] [Google Scholar]

Drilling rig UGB-210 for drilling water wells || OOO Portal

Drilling rig URB-210 with a hydraulic drive of a movable rotator is designed for drilling hydrogeological, water-reducing, ventilation, degassing, energy, freezing wells, as well as industrial water wells.

URB-210 provides drilling of:

– rotary drilling with flushing / blowing
– pneumatic shock
– impact-rotary coreless with backflush (RC)
– rotary drilling with backwash (AIRLIFT)

* – depending on the pump / compressor used and the final diameter of the well

Technical features:

• 1 type of rotator:

  – hydraulic with the possibility of retraction to the right side of the borehole axis by a hydraulic cylinder controlled from the driller’s console;

  – hydraulic with forward rotation from the drilling axis at an angle from 0 to 90 degrees, which makes it possible to safely and quickly conduct a trip during the assembly and disassembly of the drill string;

• 2nd type of rotator:

  – hydraulic with side outlet by hydraulic cylinder;

• All working parts of the unit are hydraulically driven, which makes it possible to complete with additional technological equipment without making significant changes to the design of the unit. Depending on the purpose of the application, the drilling rig can be equipped with drilling rotators (performance characteristics may differ from those given) and various mechanization devices for the SPO (pipe turners, pipe clamps, depending on the diameter of the drill string used). Reduced labor intensity of control compared to drilling rigs with mechanical transmission;
• Hydraulic control provides fine tuning and operational control while drilling;
• The driller’s workplace is organized on a folding platform, fixed on board the rear part of the installation platform;
• For the implementation of pneumatic percussion drilling in difficult geological and technical conditions, the unit can be equipped with a lubricator for submersible pneumatic percussion machines and equipment for working with hydraulic fluid;
• A wide range of fixtures and accessories, supplied on request, provides basic operations with various types of drilling tools and mechanization of auxiliary operations;

Specifications

VENDOR CODE	URB-210
TRANSPORT BASES	URAL-4320 LONG C/P – 12000 KG, KAMAZ-65111 (6X6) DOUBLE RUBBER KAMAZ-65115 (6X4) TWO-STROKE RUBBER
MAST	VERTICAL TRUSS
HEIGHT, M	14. 5
LOADING CAPACITY, TC (KN),	20 (196)
CROWN BLOCK	SINGLE-STRING; 2 x
1 ROTATION TYPE:	FOR BACKFLOW DRILLING (AIRLIFT)
ROTATION SPEED I RANGE, RPM	0 – 60
TORQUE ON THE I RANGE OF THE ROTATOR, KGSM	1500
ROTATION SPEED I RANGE, RPM	0 – 130
TORQUE ON THE I RANGE OF THE ROTATOR, KGSM	700
LOAD CAPACITY OF THE ROTATOR, KGS	20 000
SPINDLE SPINDLE DRIVE DIAMETER NOT LESS THAN, MM	130
BACKFLOW DRILLING ROTATOR EQUIPMENT WITH AN EXTERNAL COMPRESSOR	TOP SWIVEL WITH 130 MM PASSAGE LOWER AIR SWIVEL WITH INTERNAL LOCK THREAD З-171 FOR CONNECTING SPECIALIZED DRILL PIPES AND CONNECTING PNEUMATIC LINES
2 TYPE OF ROTATION:	FOR FLUSH/BLOW DRILLING
ROTATION SPEED I RANGE, RPM	0 – 75
TORQUE ON THE I RANGE OF THE ROTATOR, KGSM	1500
ROTATION SPEED II RANGE, RPM	0 – 150
TORQUE ON THE II RANGE OF THE ROTATOR, KGSM	750
ROTATION SPEED III RANGE, RPM	TO 360
TORQUE ON THE III RANGE OF THE ROTATOR, KGSM	310
LOAD CAPACITY OF THE ROTATOR, KGS	20 000
FEEDING MECHANISM	HYDRO CYLINDER WITH HAUL CHAIN/CABLE FEEDING SYSTEM
MAXIMUM DOWNHOLE FORCE, TS (KN)	10 (100)
MAXIMUM LIFT FORCE, TC (KN)	20 (196)
STROKE STROKE, MM	7100
DRILL ROD LENGTH MAX, MM	6200
WINCH MAIN:	HYDRAULIC, REVERSIBLE
WINCH DRIVE, TS	10. 0
AUXILIARY WINCH:	WITH HYDRAULIC DRIVE
WINCH DRIVE, TS	1.0
CONDITIONAL DRILLING DEPTH, M:
– WITH BACKWASH (AIRLIFT)	150
– WITH FLUSH / PURGE	800**
DRILLING DIAMETER, MM:
– WITH BACKWASH (AIRLIFT)	UP TO 1000
– WITH DIRECT RINSE INITIAL/END	UP TO 530 / UP TO 152

* – at the request of the customer
** – depending on the pumping and compressor equipment used

OLF ROBUST 210 3×1.0 LappKabel – Control cable, OLFLEX ROBUST 210, indoor and outdoor, bio-oil, UV, ozone resistant

series
Data OLFLEX

| 10904-0331

Control cable, OLFLEX ROBUST 210, indoor and outdoor, bio-oil, UV, ozone resistant, 3×1.

0 | core 1.0 mm ² , D= 6.1 mm, sheath: TPE thermoplastic elastomer, black, LappKabel | Germany

Images are for reference only and may vary slightly from
actual model

Cost OLF ROBUST 210 3×1.0

on request

Availability: call

Manufacturer

Lapp Cable

Insulation

TPE thermoplastic elastomer

Conductor

stranded copper conductor

Color

black

Norm
holidays, m 1

Availability call

Print version

ModelsDescriptionTech. Specifications

Models

Description

Description

ÖLFLEX

^® ROBUST 210

Elastic control cable

900 02
The cable is resistant to weather conditions, bio-oil,
detergents and hot water. Applicable in fields such as machine tool industry, medical
industry, washing installations, laundries, car washing installations,
chemical industry, composting plants, sewage treatment plants.

It is especially important to note the possibility of using
this cable in the food industry, in the manufacture of non-alcoholic
beverages, milk and meat processing.

• weather resistant
phenomena, ozone and UV rays
• has a wide temperature range
• universal for both internal and
for outdoor installation
• not sensitive to oils,
a large amount of fats, wax on vegetable, synthetic or animal
basis or their emulsions
• high resistance to ammonia
compounds and biogas
• high resistance to hot and
cold water, as well as water-soluble detergents and coolants
• Suitable for steam cleaning

Specifications

Specifications